Search

Author/Creator Stec-Michalska, Krystyna

1. Etrolizumab versus adalimumab or placebo as induction therapy for moderately to severely active ulcerative colitis (HIBISCUS): two phase 3 randomised, controlled trials. (January 2022)

Authors:
Rubin, David T; Dotan, Iris; DuVall, Aaron; Bouhnik, Yoram; Radford-Smith, Graham; Higgins, Peter D R; Mishkin, Daniel S; Arrisi, Pablo; Scalori, Astrid; Oh, Young S; Tole, Swati; Chai, Akiko; Chamberlain-James, Kirsten; Lacey, Stuart; McBride, Jacqueline; Panés, Julian; Abdulkhakov, Rustem; Abu ...
Journal:
Lancet gastroenterology and hepatology
Issue:
Volume 7:Number 1(2022)
Page Start:
17
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. G protein-coupled receptor 55 (GPR55) expresses differently in patients with Crohn's disease and ulcerative colitis. (3rd July 2017)

Authors:
Włodarczyk, Marcin; Sobolewska-Włodarczyk, Aleksandra; Cygankiewicz, Adam I.; Jacenik, Damian; Krajewska, Wanda M.; Stec-Michalska, Krystyna; Piechota-Polańczyk, Aleksandra; Wiśniewska-Jarosińska, Maria; Fichna, Jakub
Journal:
Scandinavian journal of gastroenterology
Issue:
Volume 52:Number 6/7(2017)
Page Start:
711
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗